GlassScriptPhysician profile
Jie Tang
NPI 1871583997
$22,666.32
in general payments reported to CMS, 2019-2025
17 companies · $6,597 in 2025
The $6,597 reported for 2025 was more than what 94% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,089 · 2020: $95.02 · 2021: $406 · 2022: $476 · 2023: $381 · 2024: $5,622 · 2025: $6,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,500 · Food and Beverage: $3,141 · Travel and Lodging: $1,943 · Education: $16.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,500.00 |
| Food and Beverage | $3,140.91 |
| Travel and Lodging | $1,942.82 |
| Education | $16.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $8,716.17 | 2019 | |
| Travere Therapeutics, INC. | $5,899.24 | 2024-2025 | |
| Calliditas Therapeutics US INC. | $5,271.65 | 2024-2025 | Tarpeyo |
| Alexion Pharmaceuticals, INC. | $554.45 | 2019-2025 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $528.47 | 2022-2025 | |
| Apellis Pharmaceuticals, INC. | $344.91 | 2025 | Empaveli |
| Astrazeneca Pharmaceuticals LP | $269.95 | 2019-2024 | |
| Akebia Therapeutics INC | $246.60 | 2024-2025 | Vafseo, Auryxia |
| Otsuka America Pharmaceutical, INC. | $138.86 | 2020-2023 | Jynarque |
| Glaxosmithkline, LLC. | $122.66 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $121.43 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $103.68 | 2022 | |
| Amgen INC. | $103.67 | 2023 | Parsabiv |
| Fresenius USA Marketing, INC. | $93.70 | 2019 | |
| Nxstage Medical, INC. | $79.54 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $52.58 | 2024 | |
| Baxter Healthcare | $18.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jie Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.